Showing 4,361 - 4,380 results of 9,864 for search '"drug"', query time: 0.07s Refine Results
  1. 4361

    Daygurt: A functional drink combining dadih and yoghurt from cow’s milk using response surface methodology by Gusnedi, Ahmad Habibi Nur, Sartika Wiwi, Darwel, Tristi Utami Citra

    Published 2025-01-01
    “…Quality and safety assessment confirmed that Daygurt complied with the standards established by the Indonesian Food and Drug Authority.…”
    Get full text
    Article
  2. 4362

    Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population by Andrew E. Stine, Jignesh Parmar, Amy K. Smith, Zachary Cummins, Narasimha Rao Pillalamarri, R. Joseph Bender

    Published 2025-01-01
    “…Abstract Challenges in drug development for rare diseases such as pulmonary arterial hypertension can be addressed through the use of mathematical modeling. …”
    Get full text
    Article
  3. 4363

    Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease by Allison P. Watson, Claudio G. Brunstein, Shernan G. Holtan

    Published 2018-01-01
    “…This case report highlights the importance of vigilance for severe side effects in novel immunosuppressive drug combinations.…”
    Get full text
    Article
  4. 4364

    Ranitidine bismuth citrate: A review by N Chiba, RH Hunt, ABR Thomson

    Published 2001-01-01
    “…RBC, used alone or in combination with other antibiotics, appears to be a safe and effective drug for the treatment of H pylori infection. Bismuth levels do not appear to rise to toxic levels.…”
    Get full text
    Article
  5. 4365

    Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation by Gregory M. Halenda, Stylianos Voulgarelis

    Published 2021-01-01
    “…While liposomal bupivacaine is not currently FDA-approved for peripheral nerve blockade in children, this case highlights a potentially effective use of this drug and possible area for further investigation.…”
    Get full text
    Article
  6. 4366

    Exogenous Pulmonary Surfactant as a Vehicle for Antimicrobials: Assessment of Surfactant-Antibacterial Interactions In Vitro by Alexei Birkun

    Published 2014-01-01
    “…Owing to its unique surface-active properties, an exogenous pulmonary surfactant may become a promising drug delivery agent, in particular, acting as a vehicle for antibiotics in topical treatment of pneumonia. …”
    Get full text
    Article
  7. 4367

    Inhalation Techniques Used in Patients with Respiratory Failure Treated with Noninvasive Mechanical Ventilation by Patrycja Rzepka-Wrona, Szymon Skoczynski, Dawid Wrona, Adam Barczyk

    Published 2018-01-01
    “…Aerosol therapy is often necessary for patients receiving noninvasive ventilation (NIV), which may be stopped for the time of drug delivery and administered through a metered-dose inhaler or nebulizer in the traditional way. …”
    Get full text
    Article
  8. 4368

    Proposing a new anti-Covid-19 agent by using molecular docking and dynamics simulations by Izabella Rodrigues Fonseca da Silva, Luís Felipe Guerreiro Martins, Julliane Yoneda

    Published 2025-01-01
    “…The main protease (Mpro) of SARS-CoV-2 is considered one of the important drug targets for the treatment of Covid-19. Recent studies have shown that anisotine should be a potent Mpro inhibitor. …”
    Get full text
    Article
  9. 4369

    Staphylococcus aureus blocks host autophagy through circSyk/miR-5106/Sik3 axis to promote progression of bone infection. by Zhihao Chen, Qiyuan Jin, Jinqi Zhong, Zonggang Xie, Qi Chen, Liubing Li, Jijie Li, Chenhao Zhao, Junfeng Wang, Xiaoying Tang, Mingxiao Han, Ru Li, Ziyuan Li, Zelei Tong, Min Wang, Hong Du, Haifang Zhang

    Published 2025-01-01
    “…Methicillin-resistant Staphylococcus aureus (S. aureus) and other emerging fully drug-resistant strains make the management of bone infections even more challenging. …”
    Get full text
    Article
  10. 4370

    Using Anterior Segment Optical Coherence Tomography to Monitor Disease Progression in Peripheral Ulcerative Keratitis by Aakriti Garg, Joaquin De Rojas, Priya Mathews, Albert Hazan, James Lin, Danielle Trief, Leejee H. Suh

    Published 2018-01-01
    “…The first patient had prolonged nonsteroidal anti-inflammatory drug use, while the second had inflammatory arthritis by laboratory findings without any systemic findings as well as possible concurrent tuberculosis. …”
    Get full text
    Article
  11. 4371

    Clinical Biology and Potential Use of Thrombopoietin by Russell Basser

    Published 2000-01-01
    “…However, one of these agents, interleukin-11, was successfully shown to reduce the incidence of severe thrombocytopenia in patients receiving dose-intensive chemotherapy, and has now received approval from the United States Food and Drug Administration for this purpose. Initial clinical trials of thrombopoietin, the central regulator of megakaryocytopoiesis and thrombopoiesis, and its analogues showed these agents to be the most potent stimulators of thrombopoiesis and to be associated with few adverse effects. …”
    Get full text
    Article
  12. 4372

    Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease by Leslie B. Tolle

    Published 2022-01-01
    “…The three case studies described in this article illustrate the challenges in the diagnosis and management of patients with fibrosing ILDs and the importance of taking a multidisciplinary and individualized approach to care, including regular monitoring and consideration of whether a patient’s drug regimen needs to be changed when there is evidence of disease progression.…”
    Get full text
    Article
  13. 4373

    “A Dangerous Black Box:” Idiopathic Hemophagocytic Lymphohistiocytosis in Adult Patients—A Case Report and Review of the Literature by Nada Agbariah, Javier Sanz, Alicia Rovó

    Published 2022-01-01
    “…The patient showed a favorable response and did not require further hospitalization; however, one year after diagnosis, it was not possible to suspend cyclosporine due to recurrence of laboratory inflammation signs by drug tapering. The occurrence of HLH idiopathic forms represents a challenge; failure to identify the underlying triggering cause generates uncertainty, endless diagnostic investigations, and consequently additional delays in the treatment. …”
    Get full text
    Article
  14. 4374

    The Anticancer Perspective of Tangeretin: A Small Review by Yuan Xu, Xi Yan, Junpeng Zhuang, Haijun Hao

    Published 2025-01-01
    “…Tangeretin can also work with other chemotherapy drugs, such as cisplatin, to reduce the drug resistance of cancer cells and improve the therapeutic effect of chemotherapy drugs. …”
    Get full text
    Article
  15. 4375

    Dynamics of agonist-evoked opioid receptor activation revealed by FRET- and BRET-based opioid receptor conformation sensors by Sina B. Kirchhofer, Claudia Kurz, Lorenz Geier, Anna-Lena Krett, Cornelius Krasel, Moritz Bünemann

    Published 2025-02-01
    “…Abstract The opioid receptor family, particularly the µ opioid receptor, are the main drug targets in the management of severe pain. However, their pain-relieving effects are often accompanied by severe adverse effects, underlining the necessity for extensive research on this receptor family. …”
    Get full text
    Article
  16. 4376

    An Optimized Protocol for Simultaneous Propagation of Patient-derived Organoids and Matching CAFs by Jenny Högström, Taru Muranen

    Published 2025-01-01
    “…Our matching PDOs and CAFs will provide researchers with a new resource to study the influence of the tumor microenvironment on various aspects of cancer biology such as cell growth and drug resistance in HR+ breast cancer.…”
    Get full text
    Article
  17. 4377

    Mitoxantrone and acquired Long-QT Syndrome. Case presentation. by Brandy Viera Valdés, Lázaro Enrique De la Cruz Aviléz

    Published 2009-05-01
    “…The acquired Long-QT Syndrome can be caused by more than 100 non anti-arrhythmic drugs. These drugs block potassium channels; particularly the IKr which extends the ventricular repolarization beyond 450 ms. …”
    Get full text
    Article
  18. 4378

    Recurrent Thrombotic Vasculopathy in a Former Cocaine User by Preeti Jadhav, Hassan Tariq, Masooma Niazi, Giovanni Franchin

    Published 2015-01-01
    “…She was incarcerated and attended a drug rehabilitation program after which she quit cocaine use, which was consistent with negative urine toxicology on subsequent admissions. …”
    Get full text
    Article
  19. 4379

    Preventing Foodborne Illness: E. coli “The Big Six” by Susanna Richardson, Renée M. Goodrich-Schneider, Keith R. Schneider

    Published 2013-10-01
    “…In addition to E. coli O157:H7, the U.S. Food and Drug Administration has identified six serogroups (or “strains”), known as the “big six,” which includes E. coli O26, O45, O103, O111, O121, and O145. …”
    Get full text
    Article
  20. 4380

    Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners by Costas Thomopoulos, Helena Michalopoulou, Alexandros Kasiakogias, Anna Kefala, Thomas Makris

    Published 2011-01-01
    “…Impaired sodium handling, sympathetic activation, accelerated arterial stiffening, and impaired cardiorenal hemodynamics contribute to drug-resistant hypertension development in obstructive sleep apnea. …”
    Get full text
    Article